Related Experiment Video
Updated: Jul 4, 2026

Detection of Extravascular Trypanosoma Parasites by Fine Needle Aspiration
Published on: August 7, 2019
Fine needle aspiration in the diagnosis of thymic epithelial neoplasms
1Department of Pathology, Ohio State University College of Medicine, 414 Doan Hall, 410 West 10th Avenue, Columbus, OH 43210, USA. paul.wakely@osumc.edu
Insights
Fine-needle aspiration (FNA) biopsy for thymoma presents challenges due to numerous lymphocytes. While FNA can identify thymoma and thymic carcinomas, it cannot determine subtypes or invasion extent.
Area of Science:
- Cytopathology
- Thoracic oncology
- Diagnostic pathology
Background:
- Fine-needle aspiration (FNA) biopsy is crucial for diagnosing thymoma.
- Benign lymphocytes often obscure epithelial cells in thymoma FNA, complicating diagnosis.
Purpose of the Study:
- To evaluate the diagnostic utility and limitations of FNA in thymoma and thymic carcinoma.
- To highlight challenges in differentiating thymoma subtypes and assessing invasion via cytology.
Main Methods:
- Review of cytopathologic findings from FNA biopsies of thymoma and thymic carcinoma.
- Analysis of diagnostic accuracy and limitations based on cytologic features.
Main Results:
- FNA requires a dual population of epithelial cells and lymphocytes in the correct clinical context for thymoma diagnosis.
- FNA can recognize thymic carcinomas but cannot reliably differentiate subtypes or determine invasion.
- Distinguishing moderately differentiated from poorly differentiated neuroendocrine carcinomas is generally not possible with FNA.
Conclusions:
- FNA is valuable for initial diagnosis of thymoma and thymic carcinoma but has limitations.
- Cytologic assessment alone is insufficient for subtyping thymoma or evaluating capsular/local invasion.
- Further investigation is needed to overcome FNA limitations in specific thymic neoplasms.
Abstract:
Fine-needle aspiration (FNA) biopsy of thymoma is a demanding diagnostic exercise by the cytopathologist because of an overwhelming, often obscuring population of benign lymphocytes in many cases. Diagnosis requires the presence of a dual population of unequivocal epithelial cells and lymphocytes in the correct clinical-radiologic context. Cytologic examination alone is not insufficient to discriminate among the various subtypes of thymoma, nor can capsular invasion or invasion of adjacent structures be determined using FNA. The cytopathology of various thymic carcinomas (including neuroendocrine carcinoma) imitate their appearance in extra-thymic sites, and are generally recognizable using FNA. Separation of moderately differentiated neuroendocrine carcinoma from poorly differentiated small cell neuroendocrine carcinomas is generally not possible.

